Neurologia i Neurochirurgia Polska

Papers
(The TQCC of Neurologia i Neurochirurgia Polska is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
LRRK2 R1441C mutation causing Parkinson’s Disease in an Egyptian family39
Relevance of admission hyperglycaemia and diabetes mellitus to efficacy and safety of mechanical thrombectomy in stroke patients30
Sex-related patient-reported brain fog symptoms in non-hospitalised COVID-19 patients21
Safety, efficacy and steroid-sparing effect of amifampridine in Lambert-Eaton myasthenic syndrome patients — real world data21
Recurrence of cerebrospinal fluid-venous fistulas at different spinal levels following transvenous embolisation or blood/fibrin glue patching21
Haemorrhagic intracranial complications associated with vaccine-induced thrombocytopenia or central venous thrombosis after COVID-19 vaccination: postulated underlying mechanisms with literature and c19
C9orf72 hexanucleotide repeat expansion found in suspected spinobulbar muscular atrophy (SBMA)15
Deep brain stimulation of hippocampus in treatment of refractory temporal lobe epilepsy14
Mechanical thrombectomy in very elderly people: shortand long-term outcomes of endovascular stroke treatment in nonagenarians14
Ambiguities in blood pressure management in acute ischaemic stroke13
Risk factors for reoperation after surgical treatment for degenerative spinal disease in Poland: a nationwide retrospective study of 38,953 hospitalisations13
Does ASTRAL score at hospital admission predict symptomatic haemorrhagic transformation in acute ischaemic stroke after revascularisation? A pilot single-centre study13
Common therapeutic approaches in sleep and awake bruxism — an overview13
Response to ‘Neuro-COVID due to the response against the virus’ Letter13
Management of autoimmune temporal lobe epilepsy with GAD65 antibody: four case reports13
Multisystem presentation of Late Onset Pompe Disease: what every consulting neurologist should know12
Alzheimer’s disease and type 2 diabetes mellitus: similarities in pathomechanisms lead to therapeutic opportunities12
Movement disorders associated with chromosomal aberrations diagnosed in adult patients11
Effects of sex and APOE on Parkinson’s Disease-related cognitive decline11
Does botulinum toxin type A treatment influence non-motor symptoms in cervical dystonia patients? A systematic review10
Response to Letter to the Editors entitled ‘Neurotoxicity of levodopa/carbidopa intestinal gel preparations can cause polyneuropathy in Parkinson‘s patients‘10
Predictors for long-term incomplete nidus obliteration following stereotactic radiosurgery for brain arteriovenous malformations: a systematic review and meta-analysis9
From rarity to reality: Poland’s first case of neurological Erdheim-Chester Disease with cerebellar manifestations8
Response to ‘Before blaming levodopa/carbidopa intestinal gel for demyelinating polyneuropathy, all differential aetiologies must be ruled out’8
Response to ‘Neurologists should retain diagnostic and therapeutic management of migraines’8
Paraneoplastic cerebellar degeneration — raising awareness for early diagnosis8
Choroid plexus imaging in multiple sclerosis management — a systematic review8
Latest bibliometrics of Polish Journal of Neurology and Neurosurgery8
Predicting haemorrhagic transformation through serum biochemical indices for patients after endovascular treatment: a retrospective study8
Safety and efficacy of short percutaneous fixation in AO3 and AO4 lumbar fractures: a single-centre experience of 35 cases7
Screening for PRKN and PINK1 mutations in Ecuadorian patients with early-onset Parkinson’s Disease7
Venous return in acute ischaemic stroke patients measured during computed tomography angiography of head and neck7
Excessive supraventricular activity and risk of atrial fibrillation in patients with cryptogenic ischaemic stroke7
Prevalence of ruptured small and very small aneurysms: a retrospective single-centre study7
Post-COVID 19 Neurological Syndrome: a fresh challenge in neurological management6
Nucleus accumbens as a stereotactic target for the treatment of addictions in humans: a literature review6
Unruptured intracranial aneurysm volume change patterns and association with age, sex, location in vascular tree, and common risk factors: a single-centre retrospective study6
Challenges of equitable access to device-aided therapies for advanced Parkinson’s Disease in Poland — expert consensus and treatment recommendations6
YouTube as a source of patient information on brain aneurysms: a content-quality and audience engagement analysis6
Clinical and radiological consequences of delayed therapy escalation in patients with relapsing-remitting multiple sclerosis6
Heart Rate Variability in evaluation of autonomic dysfunction in idiopathic REM-sleep behaviour disorder6
Migraine in the elderly — diagnosis and treatment: a single-centre experience6
Cognitive impairment in chronic migraine compared to pseudotumor cerebri6
Increasing role of imaging in differentiating MS from non-MS and defining indeterminate borderline cases6
Bed regime as a lifesaving factor in spontaneous intracranial hypotension6
Unexpected infiltration of meninges by generalised diffuse large B-cell lymphoma manifesting as multiple cranial neuropathies in a patient with history of breast carcinoma5
Herpes zoster prevention in multiple sclerosis and neuromyelitis optica spectrum disorders5
Neurologists should retain diagnostic and therapeutic management of migraines5
Effects of idebenone treatment in a patient with DNAJC30-associated Leigh Syndrome5
Structural brain assessment of temporal lobe epilepsy based on voxel-based and surface-based morphological features5
Acute-onset chorea and confusional state in 77-year-old COVID-19 patient: a case report5
Erdheim-Chester disease is often complicated by neurological disorders5
Comparison of autonomic dysfunction in patients with Parkinson’s Disease, progressive supranuclear palsy, and multiple system atrophy4
Course of fatigue among patients previously hospitalised due to COVID-194
Elevated tissue factor pathway inhibitor is associated with intracerebral haemorrhage of unknown cause in young adults4
Differences in subcortical functional connectivity in patients with epilepsy4
SARS-CoV-2 infection complicated by neuro- or psycho-COVID4
Cladribine tablets for highly active relapsing-remitting multiple sclerosis in Poland: a real-world, multi-centre, retrospective, cohort study during the COVID-19 pandemic4
Clinical, immunological and neuroimaging spectrum of CNS lupus: can we reliably differentiate it from MS?4
Effect of levetiracetam on nocturnal sleep in patients with epilepsy4
Rowland Payne syndrome mimicking motor neuron disease4
Is remission in women with idiopathic generalized epilepsy possible without valproate?4
Acute kidney injury negatively affects short and long-term outcomes of mechanical thrombectomy in acute ischaemic stroke4
Response to the Letter to the Editors on the article reviewing the complex subject of ‘Impact of SARS-CoV-2 on the nervous system’4
Reperfusion therapy of ischaemic strokes in oral anticoagulated patients: an expanding field in clinical practice4
Patterns of antiseizure medication use in pregnant women with epilepsy: a 24-year observation in Poland4
Response to: DNAJC30 variants can also manifest phenotypically as Leigh/LHON overlap syndrome4
Differences in prevalence of orthostatic hypotension between Parkinson’s Disease motor subtypes4
Is deep brain stimulation effective in Huntington’s Disease? — a systematic literature review4
Pneumocephalus as a rare complication: a systematic review plus clinical vignette4
Impact of treatment on blood-brain barrier impairment in Wilson’s disease4
Disease-modifying therapy in multiple sclerosis: recommendations of Multiple Sclerosis and Neuroimmunology Section of Polish Neurological Society4
Carbohydrate metabolism and lipid profile in patients with Parkinson’s disease with subthalamic deep brain stimulation3
Predictors of cognitive impairment in pseudotumor cerebri3
Two cases of delayed onset, fully reversible cortical oedema and signal intensity on brain MRI without infarction caused by prolonged migraine aura3
Differences in diffusion tensor imaging parameters of brain white matter tracts between patients with myotonic dystrophy type 1 and type 2 — a retrospective single-centre study3
Prognostic significance of age in patients with acute ischaemic stroke treated with intravenous thrombolysis3
Screening and diagnosis for mood and anxiety disorders in epilepsy: Polish population reference values3
Primary progressive multiple sclerosis overlapping with anti-GAD and anti-Hu antibodies positive neurological syndromes3
D-penicillamine-induced lupus erythematosus as an adverse reaction of treatment of Wilson’s Disease3
Reversing dabigatran effect with idarucizumab to enable intravenous thrombolysis in patients with acute ischaemic stroke — a single centre experience3
Clinical significance and prognostic value of serum autoantibody tests in multiple sclerosis3
Clinical and laboratory parameters by age for patients diagnosed with multiple sclerosis between 2000 and 20153
Polish recommendations for diagnosis and therapy of paediatric stroke3
Response to Letter to the Editors regarding article entitled ‘Left ventricular non-compaction cardiomyopathy and ischaemic stroke’3
Open imaging protocols, amyotrophic lateral sclerosis and other neurodegenerative disorders3
COVID-19 pandemic year in a sample of Polish myasthenia gravis patients: an observational study3
Do Parkinson’s Disease clinical subtypes really exist?3
Vocational activity for patients with multiple sclerosis3
Surgical treatment of brainstem cavernomas using diffusion tensor imaging and diffusion tensor tractography3
Long-term cenobamate retention, efficacy, and safety: outcomes from Expanded Access Programme3
Editorial Board meeting of the Polish Journal of Neurology and Neurosurgery — announcement of the gold open access for the journal3
The assessment of cognitive and behavioural disturbances in vascular cognitive impairment (VCI) — recommendations of an expert working group3
Role of neuroinflammation factors as potential biomarkers of epilepsy: a narrative review3
Overlapping challenges of treating cerebrospinal fluid dynamic disorders3
Impact of SARS-CoV-2 on the nervous system3
Olfactory dysfunction in patients with Wilson’s Disease3
0.080199956893921